摘要
可用特异性单克隆抗体检测的人肝细胞癌的相关蛋白在早期诊断上有重要意义;基于抗体的生物治疗(尤其是免疫治疗)有多种途径,有些方法前景看好。免疫治疗中存在的问题有待进一步克服,应用于临床也必须和其他手段相结合。
Antigens associated with human hepatocellular carcinoma that can be detected by specific monoclonal antibodies play a critical role in the early diagnosis. Antibody-based immunotherapeutic methods have been exploited by different means and some of them have shown encouraged results. Obstacles in these strategies need to be resolved and combination with other treatments is necessary in the clinical application to exhibit their real values.
出处
《生物技术通讯》
CAS
1997年第2期70-73,共4页
Letters in Biotechnology
